Mild headache, dizziness, or fatigue
Because this is a delicate pain relief injection , careful preparation is essential
While GHK-Cu is recognized for its broad regenerative capabilities, AHK-Cu is more selectively targeted, acting primarily on the microenvironment of the scalp
The peptide remains unregulated by the FDA, meaning it has not undergone the safety and efficacy validation required for therapeutic claims
Serono Laboratories voluntarily discontinued Geref in 2008 due to manufacturing difficulties, not safety concerns
Transient light-headedness, dizziness, or nausea can occur, especially with high or rapidly infused doses